Chong-Sheng Yuan

This inventor holds 26 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Biochemical Assays. Top assignees: General Atomics, Inc., Diazyme Laboratories, Inc.. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chong-Sheng Yuan. Retrieved from https://idiyas.com/inventor/chong-sheng-yuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 6)

% Patents Active = 65.4

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 99(Granted Patents)

Company Filing History:

24 out of 325

General Atomics, Inc.

patents

2 out of 2

Diazyme Laboratories, Inc.

patents

Years Active: 2002-2024

Loading Chart...

Areas of Expertise:

Biochemical Assays

Glycated Hemoglobin

Homocysteine

Ion-Sensitive Enzymes

Enzyme Cycling

S-Adenosyl-L-Homocysteine

Potassium Detection

Vitamin D Assays

Reversible Inhibitors

Substrate Composition

Monitoring Analytes

Hydrolase Enzymes

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12044686 - Compositions and methods for assaying neutralizing antibodies (2024-07-23),

2. 11435367 - Methods and kits for assaying a vitamin D moiety (2022-09-06),

3. 8795979 - Hydrolase enzyme substrates and uses thereof (2014-08-05),

4. 8673646 - Electrochemical biosensor for direct determination of percentage of glycated hemoglobin (2014-03-18),

5. 8557591 - Methods for assaying percentage of glycated hemoglobin (2013-10-15),

6. 8476034 - Methods and compositions for assaying homocysteine (2013-07-02),

7. 8338184 - Methods for assaying percentage of glycated hemoglobin (2012-12-25),

8. 8318501 - Methods for assaying percentage of glycated hemoglobin (2012-11-27),

9. 8187831 - Determination of ions using ion-sensitive enzymes (2012-05-29),

10. 8168643 - Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof (2012-05-01),

11. 7943385 - Methods for assaying percentage of glycated hemoglobin (2011-05-17),

12. 7868011 - Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus (2011-01-11),

13. 7855079 - Methods for assaying percentage of glycated hemoglobin (2010-12-21),

14. 7517887 - Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof (2009-04-14),

15. 7384760 - Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase (2008-06-10),

Title: **Chong-Sheng Yuan: Innovator in Antibody Assaying and Vitamin D Research**

Introduction

Chong-Sheng Yuan, based in San Diego, CA, is a prolific inventor with an impressive portfolio of 26 patents. His contributions primarily focus on innovative methods for assaying antibodies and vitamin D, showcasing his dedication to advancing research in the biomedical field.

Latest Patents

Yuan's most recent patents include groundbreaking compositions and methods for analyzing neutralizing antibodies to SARS-CoV-2. This invention provides techniques for examining patient samples suspected of containing the virus, aiding in the diagnosis and recovery processes. Additionally, he has developed methods and kits for assaying vitamin D moieties, leveraging specific antibodies to measure vitamin D content in samples through an agglutination reaction, highlighting his focus on health and wellness innovations.

Career Highlights

Throughout his career, Yuan has made significant contributions while working with esteemed organizations such as General Atomics, Inc. and Diazyme Laboratories, Inc. His experience in these companies has enabled him to refine his expertise in developing practical solutions for complex healthcare challenges.

Collaborations

Chong-Sheng Yuan has collaborated with notable professionals in his field, including Abhijit Datta and Limin Liu. These partnerships have enriched his research endeavors, allowing for the exchange of ideas and the development of innovative technologies in the realm of biomedical science.

Conclusion

With a robust portfolio of patents and a commitment to innovation, Chong-Sheng Yuan stands out as a key figure in the development of methods for antibody analysis and vitamin D testing. His work not only contributes to scientific understanding but also has the potential to impact public health significantly.

Profile summary based on public USPTO records.